Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients

Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents

(2013) Carlos Juárez-López et al.   PEDIATRIC DIABETES

Long-chain n−3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial

(2012) Bianca K Itariu et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

The Fatty Acid Amide Hydrolase (FAAH) Gene Variant rs324420 AA/AC is not Associated with Weight Loss in a 1-Year Lifestyle Intervention for Obese Children and Adolescents

(2011) N. Knoll et al.   HORMONE AND METABOLIC RESEARCH

The Epidemiology of Obesity

(2010) Dang M. Nguyen et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets

(2010) Daniel Antonio Deluis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss after a hypocaloric diet

(2010) Daniel Antonio de Luis et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The Fatty Acid Amide Hydrolase (FAAH) Pro129Thr Polymorphism is not Associated with Severe Obesity in Greek Subjects

(2008) D. Papazoglou et al.   HORMONE AND METABOLIC RESEARCH